The Canadian cancer care landscape is changing, with the emergence of immunotherapy-based anticancer treatments that have demonstrated significant clinical benefit for many types of cancer.
The COVID-19 pandemic has presented incredible challenges for pharmacists and pharmacy staff, whether working in hospitals, community pharmacies or primary care clinics.